H.R. 9495, the Department of Defense Appropriations Act for Fiscal Year 2027, allocates $1.072 trillion to fund the U.S. military. This funding covers military pay and benefits, operations, training, procurement of equipment and weapons, research and development, and infrastructure. The bill emphasizes enhancing America's strategic military advantage by investing in new munitions, hypersonic weapons, and defense innovation programs. It also includes provisions to support allies like Taiwan and Jordan, enforces domestic sourcing requirements for military purchases, and imposes restrictions on fund usage to ensure accountability. Notably, the bill proposes renaming the Department of Defense to the Department of War.
Supporters, including Defense Subcommittee Chairman Ken Calvert, praise the bill for fulfilling the commitment to keep America safe and ensuring the U.S. military remains the strongest fighting force in the world. They highlight the bill's focus on acquiring and producing the munitions, weapons, and technology necessary for modern and future warfare, as well as its investment in defense innovation programs to provide warfighters with game-changing technologies.
Critics express concern over the substantial increase in defense spending, questioning the necessity and sustainability of such a significant budget. They argue that the allocation of $1.072 trillion could divert resources from other critical areas such as education, healthcare, and infrastructure. Additionally, some view the proposed renaming of the Department of Defense to the Department of War as a symbolic shift that may have diplomatic implications and could be perceived negatively by international partners.
The analysis of H.R. 9495 reveals no direct industry overlaps between the sponsor Ken Calvert's top donor industries and the bill's subject matter, which pertains to Department of Defense appropriations. Calvert's largest donor industry is Health Professionals, contributing $520 million, followed by Retired individuals at $162.5 million. However, these contributions do not appear to directly influence defense spending or appropriations. The lobbying activity in this area includes various organizations, but none are directly linked to Calvert's top donors, indicating a lack of immediate conflict of interest. Voters should be aware that while significant funds are involved, the absence of direct industry ties suggests a low risk of conflicts affecting the bill's integrity.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| AMERICAN COLLEGE OF CLINICAL PHARMACY | AMERICAN COLLEGE OF CLINICAL PHARMACY | $144,981 |
| ALTRIA CLIENT SERVICES | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | $40,000 |
| CROHN'S & COLITIS FOUNDATION | CROHN'S & COLITIS FOUNDATION | $40,000 |
| GOTRIANGLE | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | $30,000 |
| AFRICAN AMERICAN ALLIANCE OF CDFI CEOS | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | $20,000 |
| BRISTOL MYERS SQUIBB | ALEXANDER J. BECKLES, L.L.C. | $20,000 |
| CITY OF GLADEWATER, TEXAS | LONE STAR CONSULTING, LLC | $12,000 |
| CITY OF CRANDALL, TEXAS | LONE STAR CONSULTING, LLC | $10,000 |
| CITY OF JUSTIN, TEXAS | LONE STAR CONSULTING, LLC | $10,000 |
| THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES | MAGILL ASSOCIATES, LLC | undisclosed |
| OPPORTUNITIES INDUSTRIALIZATION CENTER OF AMERICA, INC. | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | undisclosed |
| LUMBEE TRIBE HOLDINGS, INC. | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | undisclosed |
| CITY OF CLEVELAND, TEXAS | LONE STAR CONSULTING, LLC | undisclosed |
| CITY OF RIO HONDO, TEXAS | LONE STAR CONSULTING, LLC | undisclosed |
| HOWARD COUNTY, TEXAS | LONE STAR CONSULTING, LLC | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Ken Calvert, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
